News
Our Clients
We partner with companies of all sizes, across industries, to drive innovation strategy and provide practical guidance and advice, corporate training and talent recruitment services. The true potential of AI is unlocked when you build internal capabilities, and that’s where we excel.Here are our industry partners and clients that we have supported through their AI adoption journey since 2018.
Multinationals
Canadian Industry Leaders
Startup and Scaling Tech Companies
- 2S Water Inc.
- Cognitive Diagnosis
- DOT Technology: acquired - now part of Raven Autonomy
- DrugBank
- EHS Analytics
- Frettable
- FunnelAI
- Hoot Research
- Integral Engineering
- Medo AI
- Mikata Health
- Samdesk
- TestFire Labs
Meet our Investments and Partnerships Team
Nella Brodett and Christy Holtby are keen to meet with you to chat more about how we can support your AI adoption journey. Read more about our process and offerings.
Latest News Articles
Apr 7th 2021
News
AI Seminar Series 2021: Dustin Morrill - Hindsight Rationality and Deviation Types in EFGs
On March 26, Amii's Dustin Morrill, Ph.D. candidate at the University of Alberta, presented “Hindsight Rationality and Deviation Types in EFGs.”
Apr 1st 2021
News
AI Seminar Series 2021: Kamalika Chaudhuri - New Case Studies in Inferential and Differential Privacy
On March 12, Kamalika Chaudhuri, Assistant Professor at the Computing Science & Engineering Department at the University of California San Diego, presented “New Case-Studies in Inferential and Differential Privacy.”
Mar 23rd 2021
News
Roche Canada Artificial Intelligence Centre of Excellence opens digital competition to tackle ALS
The AI CoE is collaborating with Answer ALS and EverythingALS to launch an initiative called the End ALS Challenge, with the support of ALS Society of Canada, Ontario Brain Institute (OBI) and NetraMark Corp. The goal is to surface insights through an open data competition that connects the global AI and neuroscience communities to better understand the overall biology of amyotrophic lateral sclerosis (ALS), and improve diagnosis and drug discovery for ALS patients.
